摘要
眼睛的特殊的生理解剖结构和许多药物分子的少数的理化性能经常是造成由传统剂型治疗的眼科疾病无效,这证明了创新的眼部给药系统的发展是必须的。脂质纳米载体(LNC)是较新的和引人关注的胶状药物给药系统;它们显示了通过多种给药眼部途径提高药物制剂的局部生物利用度和治疗作用的性能。此外,它们极度的生物降解性和生物相容性确保了他们“纳米安全载体”的头衔。这篇综述对LNC [也就是,固体脂质纳米颗粒(SLN),纳米结构的脂质载体(NLC)和脂质药物偶联物(LDC)] 的主要性质;实例和这些胶体载体系统应用于眼科疾病用药的优点进行了展示。
关键词: 药物传递系统,脂质药物偶联物(LDC),纳米医学,纳米结构的脂质载体(NLC),眼科学,固体脂质纳米粒(SLN)
Current Medicinal Chemistry
Title:Lipid Nanocarriers (LNC) and their Applications in Ocular Drug Delivery
Volume: 22 Issue: 13
Author(s): Carmelo Puglia, Alessia Offerta, Claudia Carbone, Francesco Bonina, Rosario Pignatello and Giovanni Puglisi
Affiliation:
关键词: 药物传递系统,脂质药物偶联物(LDC),纳米医学,纳米结构的脂质载体(NLC),眼科学,固体脂质纳米粒(SLN)
摘要: The peculiar physio-anatomical structure of the eye and the poor physico-chemical properties of many drug molecules are often responsible for the inefficient treatment of ocular diseases by conventional dosage forms, and justify the development of innovative ocular drug delivery systems. Lipid-based nanocarriers (LNC) are among the newer and interesting colloidal drug delivery systems; they show the capability to improve the local bioavailability of drugs administered by various ocular routes and, therefore, their therapeutic efficacy. Furthermore, their extreme biodegradability and biocompatible chemical nature have secured them the title of ‘nanosafe carriers.’ This review treats the main features of LNC [namely, solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and lipid-drug conjugates (LDC)]; examples and advantages of the application of these colloidal carrier systems for the ophthalmic administration of drugs are presented.
Export Options
About this article
Cite this article as:
Carmelo Puglia, Alessia Offerta, Claudia Carbone, Francesco Bonina, Rosario Pignatello and Giovanni Puglisi , Lipid Nanocarriers (LNC) and their Applications in Ocular Drug Delivery, Current Medicinal Chemistry 2015; 22 (13) . https://dx.doi.org/10.2174/0929867322666150209152259
DOI https://dx.doi.org/10.2174/0929867322666150209152259 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Vascular Endothelial Growth Factor Treatment in Retinal Vein Occlusions
Current Drug Therapy Synthesis and Bioactivity of (R)-Ricinoleic Acid Derivatives: A Review
Current Medicinal Chemistry Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal Urocortins: Take Them to Heart
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Monoamine Oxidases: to Inhibit or Not to Inhibit
Mini-Reviews in Medicinal Chemistry Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity
Mini-Reviews in Medicinal Chemistry Hydromorphone: Analytical Methodologies for its Determination
Current Analytical Chemistry Nicotinic Acetylcholine Receptor Agonists: A Potential New Class of Analgesics
Current Topics in Medicinal Chemistry Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Current Cardiology Reviews Controlled and Continuous Release Ocular Drug Delivery Systems: Pros and Cons
Current Drug Delivery Biochemical Markers of Renal Function
Current Medicinal Chemistry “Vascular Incontinence” and Normal-Pressure Hydrocephalus: Two Commonsources of Elderly Incontinence with Brain Etiologies
Current Drug Therapy Invasive Aspergillosis in Children and Adolescents
Current Pharmaceutical Design Technological Options for the Production of Health-Promoting Proteins and Peptides Derived from Milk and Colostrum
Current Pharmaceutical Design PDE-5 Inhibitors: Clinical Points
Current Drug Targets Pathophysiology, Diagnosis and Clinical Management of Hepatorenal Syndrome: From Classic to New Drugs
Current Vascular Pharmacology Chromogranin A as a Calcium-Binding Precursor for a Multitude of Regulatory Peptides for the Immune, Endocrine and Metabolic Systems
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics
Current Pharmaceutical Design